Leishmania cell membrane phospholipids

Leishmania cell membrane phospholipids are essential structural components that define the boundary and functional environment of the Leishmania parasite. These lipids, which include phosphatidylcholine, phosphatidylethanolamine, and various inositol-containing phospholipids, are crucial for maintaining membrane fluidity, signal transduction, and the anchoring of surface proteins like lipophosphoglycan (LPG) (PMID: 25650460). In the context of infection, these phospholipids facilitate the parasite's attachment to and entry into host macrophages, as well as its survival within the phagolysosome (PMID: 17603271). They are a validated therapeutic target, most notably for the drug miltefosine, an alkylphosphocholine analog that interferes with phospholipid metabolism and triggers apoptosis-like cell death (PMID: 22438734). Because the parasite's lipid biosynthetic pathways and specific lipid species differ from those of the human host, targeting these molecules allows for a degree of selective anti-parasitic activity. However, the similarity between some parasite and host lipids can lead to side effects, such as gastrointestinal distress and potential teratogenicity (PMID: 16107253).

Other names

Leishmanial phospholipidsLeishmania membrane lipidsParasite plasma membrane phospholipids

Inhibition of phospholipid metabolism (specifically phosphatidylcholine biosynthesis) and induction of apoptosis-like cell death through the disruption of membrane-associated signaling pathways.